Didier Hober

InstitutionUniv Lille
AddressFrance
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 2 publications in March 2021
    All Publications
    Bar chart showing 164 publications over 26 distinct years, with a maximum of 15 publications in 1996 and 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Guigon A, Faure E, Lemaire C, Chopin MC, Tinez C, Assaf A, Lazrek M, Hober D, Bocket L, Engelmann I, Alidjinou EK. Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance. J Infect. 2022 Feb; 84(2):248-288. PMID: 34437928.
      Citations: 2     Fields:    
    2. Milliere L, Engelmann I, Tinez C, Bouarouro Y, Ouafi M, Lazrek M, Prevost B, Hober D, Bocket L, Alidjinou EK. Stool samples versus nasopharyngeal specimens for the initial diagnosis of SARS-CoV-2 infection. J Med Virol. 2021 07; 93(7):4145-4146. PMID: 33666261.
      Citations:    Fields:    Translation:Humans
    3. Engelmann I, Alidjinou EK, Ogiez J, Pagneux Q, Miloudi S, Benhalima I, Ouafi M, Sane F, Hober D, Roussel A, Cambillau C, Devos D, Boukherroub R, Szunerits S. Preanalytical Issues and Cycle Threshold Values in SARS-CoV-2 Real-Time RT-PCR Testing: Should Test Results Include These? ACS Omega. 2021 Mar 16; 6(10):6528-6536. PMID: 33748564.
      Citations: 7     
    4. Alidjinou EK, Poissy J, Ouafi M, Caplan M, Benhalima I, Goutay J, Tinez C, Faure K, Chopin MC, Yelnik C, Lambert M, Hober D, Preau S, Nseir S, Engelmann I. Spatial and Temporal Virus Load Dynamics of SARS-CoV-2: A Single-Center Cohort Study. Diagnostics (Basel). 2021 Mar 03; 11(3). PMID: 33802451.
      Citations: 4     
    5. Dechaumes A, Nekoua MP, Belouzard S, Sane F, Engelmann I, Dubuisson J, Alidjinou EK, Hober D. Fluoxetine Can Inhibit SARS-CoV-2 In Vitro. Microorganisms. 2021 Feb 09; 9(2). PMID: 33572117.
      Citations: 9     
    6. Simonnet A, Engelmann I, Moreau AS, Garcia B, Six S, El Kalioubie A, Robriquet L, Hober D, Jourdain M. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19. Infect Dis Now. 2021 May; 51(3):296-299. PMID: 33495765.
      Citations: 19     Translation:HumansCells
    7. Ludvigsson J, von Herrath MG, Mallone R, Buschard K, Cilio C, Craig M, Ilonen J, Leslie D, McGeoch JEM, Schneider D, Skyler JS, Flodström Tullberg M, Hober D. Corona Pandemic: Assisted Isolation and Care to Protect Vulnerable Populations May Allow Us to Shorten the Universal Lock-Down and Gradually Re-open Society. Front Public Health. 2020; 8:562901. PMID: 33102423.
      Citations:    Translation:HumansPHPublic Health
    8. Ferlin J, Farhat R, Belouzard S, Cocquerel L, Bertin A, Hober D, Dubuisson J, Rouillé Y. Investigation of the role of GBF1 in the replication of positive-sense single-stranded RNA viruses. J Gen Virol. 2018 08; 99(8):1086-1096. PMID: 29923822.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    9. Goffard A, Lazrek M, Schanen C, Lobert PE, Bocket L, Dewilde A, Hober D. [Emergent viruses: SARS-associate coronavirus and H5N1 influenza virus]. Ann Biol Clin (Paris). 2006 May-Jun; 64(3):195-208. PMID: 16698555.
      Citations: 1     Fields:    Translation:HumansCells